Pharsight

Drugs that contain Ketotifen Fumarate

1. Acuvue Theravision With Ketotifen patents expiration

ACUVUE THERAVISION WITH KETOTIFEN Litigations
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9474746 JOHNSON JOHNSON VISN Methods for stabilizing oxidatively unstable compositions
Mar, 2028

(4 years from now)

US9962376 JOHNSON JOHNSON VISN Methods and ophthalmic devices used in the treatment of ocular allergies
Jun, 2030

(6 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Product (NP) Feb 25, 2025

Market Authorisation Date: 25 February, 2022

Treatment: NA

Dosage: DRUG-ELUTING CONTACT LENS ;OPHTHALMIC

More Information on Dosage

ACUVUE THERAVISION WITH KETOTIFEN family patents

Family Patents